Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[18F]Fluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone (RROPE) Study

NCT03707184 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03707184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[18F]Fluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone (RROPE) Study
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
October 2, 2018
Completion date
February 3, 2022
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate carcinoma, prostate carcinoma metastatic in the bone, stage iv prostate cancer